
TG6-129
CAS No. 1164464-14-5
TG6-129( TG6 129 | TG6129 )
Catalog No. M27930 CAS No. 1164464-14-5
TG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 μM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 228 | Get Quote |
![]() ![]() |
10MG | 404 | Get Quote |
![]() ![]() |
25MG | 665 | Get Quote |
![]() ![]() |
50MG | 888 | Get Quote |
![]() ![]() |
100MG | 1251 | Get Quote |
![]() ![]() |
500MG | 2538 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameTG6-129
-
NoteResearch use only, not for human use.
-
Brief DescriptionTG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 μM.
-
DescriptionTG6-129 is an antagonist of the EP2 receptor. TG6-129 suppresses PGE2-induced elevation of cAMP in cells expressing EP2 with an IC50 value of 1.6 μM. TG6-129 reduces the expression of COX-2, IL-1β, IL-6, IL-12, IL-23 and TNF-α induced by the EP2-selective agonist butaprost in P388D1 macrophages.
-
In Vitro——
-
In Vivo——
-
SynonymsTG6 129 | TG6129
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
Recptorestrogen receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1164464-14-5
-
Formula Weight491.57
-
Molecular FormulaC20H18FN5O3S3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)\C=C\c3ccc(F)cc3)cc2)s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Guo S, et al. GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models. Breast Cancer Res Treat. 2020;180(2):359-368.
molnova catalog



related products
-
2-Acetylbenzoic acid
2-Acetylbenzoic acid is more potent than 2-propionyloxybenzoic acid in inhibiting platelet function and platelet prostaglandin (PG) synthesis although the potencies of these agents were comparable in inhibiting prostacyclin (PGI2) synthesis.
-
Desogestrel
Desogestrel (Org-2969) is a third-generation 19-nortestosterone derivative progestogen and agonist of the progesterone receptor.
-
MK-1029
ADC-3680 is a potent, selective prostaglandin D2 receptor (DP2, CRTH2) antagonist for the treatment of asthma.